3.12
+0.081(+2.66%)
Currency In USD
| Previous Close | 3.04 |
| Open | 3.07 |
| Day High | 3.16 |
| Day Low | 2.98 |
| 52-Week High | 37.2 |
| 52-Week Low | 2.68 |
| Volume | 95,196 |
| Average Volume | 90,274 |
| Market Cap | 10.5M |
| PE | -0.07 |
| EPS | -43.87 |
| Moving Average 50 Days | 3.32 |
| Moving Average 200 Days | 7.04 |
| Change | 0.08 |
If you invested $1000 in Bionano Genomics, Inc. (BNGO) since IPO date, it would be worth $50.75 as of August 18, 2025 at a share price of $3.121. Whereas If you bought $1000 worth of Bionano Genomics, Inc. (BNGO) shares 5 years ago, it would be worth $7.24 as of August 18, 2025 at a share price of $3.121.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL
GlobeNewswire Inc.
Aug 07, 2025 12:00 PM GMT
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades (INEM) and colleagues from multiple French pedi
Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Aug 06, 2025 12:00 PM GMT
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 45th Annual Growth Conference on Augus
Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate
GlobeNewswire Inc.
Aug 05, 2025 12:00 PM GMT
VIA™ 7.2 transforms the workflow for optical genome mapping (OGM) data analysis with AI in constitutional genetic disorders VIA 7.2 supercharges the OGM heme workflow by allowing AI to utilize a lab’s historical results to speed future interpretation